Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Mr Chrysostomos Roukas

Back to Search
Roukas C, Miller L, Hamborg T, Gordeev V, Lindsay J, Norton C, Mihaylova B ( 2023 ) . DOP23 Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey . Journal of Crohn's and Colitis vol. 17 , ( Supplement_1 ) i87 - i88 .
Hart A, Miller L, Hamborg T, Stagg I, McGuinness S, Wileman V, Tzorovili E, Mihaylova B et al. ( 2023 ) . DOP59 What is the relationship between fatigue, pain and urgency in people with inflammatory bowel disease? Results of the IBD-BOOST survey in 8486 participants . Journal of Crohn's and Colitis vol. 17 , ( Supplement_1 ) i130 - i132 .
Feng Y, Roukas C, Russo M, Repišti S, Džubur Kulenović A, Injac Stevović L, Konjufca J, Markovska-Simoska S et al. ( 2022 ) . Cost-effectiveness of implementing a digital psychosocial intervention for patients with psychotic spectrum disorders in low- and middle-income countries in Southeast Europe: economic evaluation alongside a cluster randomised trial . Eur Psychiatry1 - 29 .
Roukas C, Syred J, Gordeev VS, Norton C, Hart A, Mihaylova B ( 2022 ) . Development and test–retest reliability of a new, self-report questionnaire assessing healthcare use and personal costs in people with inflammatory bowel disease: the Inflammatory Bowel Disease Resource Use Questionnaire (IBD-RUQ) . Frontline Gastroenterology vol. 14 , ( 1 ) 59 - 67 .
Norton C, Syred J, Kerry S, Artom M, Sweeney L, Hart A, Czuber-Dochan W, Taylor SJC et al. ( 2021 ) . Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial . Trials vol. 22 , ( 1 )
Brenner A, Belli A, Chaudhri R, Coats T, Frimley L, Jamaluddin SF, Jooma R, Mansukhani R et al. ( 2020 ) . Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial . Critical Care vol. 24 , ( 1 )
Roukas C, Quayyum Z, Patel A, Fitzsimmons D, Phillips C, Hounsome N ( 2020 ) . Developing core economic parameter sets for asthma studies: a realist review and an analytical framework . BMJ Open vol. 10 , ( 10 )
Roberts I, Shakur-Still H, Afolabi A, Akere A, Arribas M, Brenner A, Chaudhri R, Gilmore I et al. ( 2020 ) . Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial . The Lancet vol. 395 , ( 10241 ) 1927 - 1936 .
Roukas C, Tomini F, Mihaylova B ( 2019 ) . P49 UK cost-effectiveness value pyramid of asthma interventions . Thorax . Conference: Driving quality improvement through education and training vol. 74 ,
collaborators TCT ( 2019 ) . Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial . The Lancet vol. 394 , ( 10210 ) 1713 - 1723 .
Hounsome N, Roukas C ( 2018 ) . Cost-effectiveness of sacral nerve stimulation and percutaneous tibial nerve stimulation for faecal incontinence . Therapeutic Advances in Gastroenterology vol. 11 ,
Back to Search